Cargando…
Correction: A Ketogenic Diet in Combination with Gemcitabine Increases Survival in Pancreatic Cancer KPC Mice
Autores principales: | Cortez, Natalia E., Lanzi, Cecilia Rodriguez, Hong, Brian V., Xu, Jihao, Wang, Fangyi, Chen, Shuai, Ramsey, Jon J., Pontifex, Matthew G., Müller, Michael, Vauzour, David, Vahmani, Payam, Hwang, Chang-il, Matsukuma, Karen, Mackenzie, Gerardo G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035528/ https://www.ncbi.nlm.nih.gov/pubmed/36970724 http://dx.doi.org/10.1158/2767-9764.CRC-22-0510 |
Ejemplares similares
-
A Ketogenic Diet in Combination with Gemcitabine Increases Survival in Pancreatic Cancer KPC Mice
por: Cortez, Natalia E., et al.
Publicado: (2022) -
Hepatic safety profile of pancreatic cancer‑bearing mice fed a ketogenic diet in combination with gemcitabine
por: Cortez, Natalia E., et al.
Publicado: (2023) -
A Ketogenic Diet in Combination with Gemcitabine Mitigates Pancreatic Cancer-Associated Cachexia in Male and Female KPC Mice
por: Cortez, Natalia E., et al.
Publicado: (2023) -
Phospho-Aspirin (MDC-22) inhibits pancreatic cancer growth in patient-derived tumor xenografts and KPC mice by targeting EGFR: Enhanced efficacy in combination with irinotecan
por: Rodriguez Lanzi, Cecilia, et al.
Publicado: (2021) -
Correction: The Genetic Landscape of Ocular Adnexa MALT Lymphoma Reveals Frequent Aberrations in NFAT and MEF2B Signaling Pathways
por: Magistri, Marco, et al.
Publicado: (2023)